We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Working on Model-Informed Drug Development Guideline to Boost Trial Design
ICH Working on Model-Informed Drug Development Guideline to Boost Trial Design
A planned International Council for Harmonization (ICH) guideline on model-informed drug development (MIDD) will help optimize clinical trial designs, according to ICH, which estimates development of the guideline will be complete in three to four years.